Relative potency of pregabalin, gabapentin, and morphine in a mouse model of visceral pain

Canadian Journal of Anesthesia

Volumn 60, Issue 1, 2013, Pages 44-49

  Shamsi Meymandi, Manzumeh ^a,b   Keyhanfar, Fariborz ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; GABAPENTIN; MORPHINE; PLACEBO; PREGABALIN; SODIUM CHLORIDE;

ABDOMINAL WALL MUSCULATURE; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG POTENCY; MALE; MOUSE; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; REGRESSION ANALYSIS; VISCERAL PAIN; WRITHING TEST;

ACETIC ACID; AMINES; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; CYCLOHEXANECARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; GAMMA-AMINOBUTYRIC ACID; MALE; MICE; MORPHINE; PAIN MEASUREMENT; VISCERAL PAIN;

EID: 84872603082     PISSN: 0832610X     EISSN: 14968975     Source Type: Journal    
DOI: 10.1007/s12630-012-9813-6     Document Type: Article

References (28)

1. Field MJ, Cox PJ, Stott E, et al. Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proc Natl Acad Sci U S A 2006; 103: 17537-42.
2. Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain 2010; 150: 573-81.
3. Tzellos TG, Toulis KA, Goulis DG, et al. Gabapentin and pregabalin in the treatment of fibromyalgia: a systematic review and a meta-analysis. J Clin Pharm Ther 2010; 35: 639-56.
4. Meymandi MS, Sepehri G, Mobasher M. Gabapentin enhances the analgesic response to morphine in acute model of pain in male rats. Pharmacol Biochem Behav 2006; 85: 185-9.
5. Luszczki JJ, Kolacz A, Wojda E, Czuczwar M, Przesmycki K, Czuczwar SJl. Synergistic interaction of gabapentin with tiagabine in the hot-plate test in mice: an isobolographic analysis. Pharmacol Rep 2009; 61: 459-67.
6. Luszczki JJ. Dose-response relationship analysis of pregabalin doses and their antinociceptive effects in hot-plate test in mice. Pharmacol Rep 2010; 62: 942-8.
7. Stepanovic-Petrovic RM, Tomic MA, Vuckovic SM, et al. The antinociceptive effects of anticonvulsants in a mouse visceral pain model. Anesth Analg 2008; 106: 1897-903.
8. Diop L, Raymond F, Fargeau H, Petoux F, Chovet M, Doherty AM. Pregabalin (CI-1008) inhibits the trinitrobenzene sulfonic acid-induced chronic colonic allodynia in the rat. J Pharmacol Exp Ther 2002; 302: 1013-22.
9. Feng Y, Cui M, Willis WD. Gabapentin markedly reduces acetic acid-induced visceral nociception. Anesthesiology 2003; 98: 729-33.
10. O'Mahony SM, Coelho AM, Fitzgerald P, et al. The effects of gabapentin in two animal models of co-morbid anxiety and visceral hypersensitivity. Eur J Pharmacol 2011; 667: 169-74.
11. Ravnefjord A, Brusberg M, Larsson H, Lindstrom E, Martinez V. Effects of pregabalin on visceral pain responses and colonic compliance in rats. Br J Pharmacol 2008; 155: 407-16.
12. Cervero F, Laird JM. Visceral pain. Lancet 1999; 353: 2145-8.
13. Le Bars D, Gozariu M, Cadden SW. Critical analysis of animal models of acute pain. II (French). Ann Fr Anesth Reanim 2001; 20: 452-70.
14. Meymandi MS, Sepehri G. Gabapentin action and interaction on the antinociceptive effect of morphine on visceral pain in mice. Eur J Anaesthesiol 2008; 25: 129-34.
15. Reichert JA, Daughters RS, Rivard R, Simone DA. Peripheral and preemptive opioid antinociception in a mouse visceral pain model. Pain 2001; 89: 221-7.
16. Romero A, Miranda HF, Puig MM. Analysis of the opioid-opioid combinations according to the nociceptive stimulus in mice. Pharmacol Res 2010; 61: 511-8.
17. Satyanarayana PS, Jain NK, Singh A, Kulkarni SK. Isobolographic analysis of interaction between cyclooxygenase inhibitors and tramadol in acetic acid-induced writhing in mice. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 641-9.
18. Stevenson GW, Cormier J, Mercer H, et al. Targeting pain-depressed behaviors in preclinical assays of pain and analgesia: drug effects on acetic acid-depressed locomotor activity in ICR mice. Life Sci 2009; 85: 309-15.
19. Le Bars D, Gozariu M, Cadden SW. Animal models of nociception. Pharmacol Rev 2001; 53: 597-652.
20. Mogil JS, Kest B, Sadowski B, Belknap JK. Differential genetic mediation of sensitivity to morphine in genetic models of opiate antinociception: influence of nociceptive assay. J Pharmacol Exp Ther 1996; 276: 532-44.
21. Hurley RW, Chatterjea D, Rose Feng M, Taylor CP, Hammond DL. Gabapentin and pregabalin can interact synergistically with naproxen to produce antihyperalgesia. Anesthesiology 2002; 97: 1263-73.
22. Tanabe M, Ono K, Honda M, Ono H. Gabapentin and pregabalin ameliorate mechanical hypersensitivity after spinal cord injury in mice. Eur J Pharmacol 2009; 609: 65-8.
23. Gale JD, Houghton LA. Alpha 2 delta (alpha(2)delta) ligands, gabapentin and pregabalin: what is the evidence for potential use of these ligands in irritable bowel syndrome. Front Pharmacol 2011; 2: 28.
24. Tzellos TG, Papazisis G, Amaniti E, Kouvelas D. Efficacy of pregabalin and gabapentin for neuropathic pain in spinal-cord injury: an evidence-based evaluation of the literature. Eur J Clin Pharmacol 2008; 64: 851-8.
25. Bian F, Li Z, Offord J, et al. Calcium channel alpha2-delta type 1 subunit is the major binding protein for pregabalin in neocortex, hippocampus, amygdala, and spinal cord: an ex vivo autoradiographic study in alpha2-delta type 1 genetically modified mice. Brain Res 2006; 1075: 68-80.
26. Dubinsky B, Gebre-Mariam S, Capetola RJ, Rosenthale ME. The antialgesic drugs: human therapeutic correlates of their potency in laboratory animal models of hyperalgesia. Agents Actions 1987; 20: 50-60.
27. Collier HO, Dinneen LC, Johnson CA, Schneider C. The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br J Pharmacol Chemother 1968; 32: 295-310.
28. Houghton LA, Fell C, Whorwell PJ, Jones I, Sudworth DP, Gale JD. Effect of a second-generation alpha2delta ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome. Gut 2007; 56: 1218-25.